| Browse All

Beyond Air, Inc. (XAIR)

Healthcare | Medical Devices | Garden City, United States | NasdaqCM
0.54 USD +0.10 (22.192%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 0.54 -0.01 (-0.005%) ⇩ (April 17, 2026, 7:42 p.m. EDT)

Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 4:04 p.m. EDT

XAIR (Beyond Air, Inc.) is currently in a severe bear market, with a price that has fallen significantly below its 52-week low. The recent price history shows a volatile and downward trend, with no clear signs of momentum or a potential rebound. The stock's fundamentals are weak, with negative earnings, a high debt-to-equity ratio, and poor profitability. Additionally, the company has faced multiple delisting warnings and is under pressure to reverse its stock split to maintain compliance. Given the lack of dividends and the poor financial health, this stock is not suitable for either short-term or long-term investment. Investors should avoid this stock and consider more stable alternatives.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.425586
AutoARIMA0.462652
AutoETS0.480698
MSTL0.511185

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 43%
H-stat 9.08
Ljung-Box p 0.000
Jarque-Bera p 0.200
Excess Kurtosis 0.52
Attribute Value
Sector Healthcare
Debt to Equity Ratio 284.709
Revenue per Share 1.131
Market Cap 5,727,964
Forward P/E -0.33
Beta 0.53
Website https://www.beyondair.net

Info Dump

Attribute Value
52 Week Change -0.8822511
Address1 900 Stewart Avenue
Address2 Suite 301
All Time High 328.2
All Time Low 0.43
Ask 0.625
Ask Size 2
Average Analyst Rating 1.8 - Buy
Average Daily Volume10 Day 626,330
Average Daily Volume3 Month 420,375
Average Volume 420,375
Average Volume10Days 626,330
Beta 0.531
Bid 0.3776
Bid Size 2
Book Value 0.965
City Garden City
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.544
Current Ratio 5.124
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 0.5556
Day Low 0.4726
Debt To Equity 284.709
Display Name Beyond Air
Dividend Date 1,484,006,400
Earnings Call Timestamp End 1,770,987,600
Earnings Call Timestamp Start 1,770,987,600
Earnings Timestamp 1,770,989,400
Earnings Timestamp End 1,770,989,400
Earnings Timestamp Start 1,770,989,400
Ebitda -25,785,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.692
Enterprise To Revenue 2.576
Enterprise Value 17,832,964
Eps Current Year -4.05
Eps Forward -1.66
Eps Trailing Twelve Months -4.47
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.83958
Fifty Day Average Change -0.29557997
Fifty Day Average Change Percent -0.35205695
Fifty Two Week Change Percent -88.225105
Fifty Two Week High 5.84
Fifty Two Week High Change -5.296
Fifty Two Week High Change Percent -0.90684927
Fifty Two Week Low 0.43
Fifty Two Week Low Change 0.11400002
Fifty Two Week Low Change Percent 0.26511633
Fifty Two Week Range 0.43 - 5.84
Financial Currency USD
First Trade Date Milliseconds 1,528,810,200,000
Float Shares 9,412,286
Forward Eps -1.66
Forward P E -0.32771087
Free Cashflow -18,648,376
Full Exchange Name NasdaqCM
Full Time Employees 61
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0182
Gross Profits 126,000
Has Pre Post Market Data 1
Held Percent Insiders 0.044
Held Percent Institutions 0.15458
Implied Shares Outstanding 10,529,345
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,743,379,200
Last Split Date 1,752,451,200
Last Split Factor 1:20
Long Business Summary Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Long Name Beyond Air, Inc.
Market us_market
Market Cap 5,727,964
Market State CLOSED
Max Age 86,400
Message Board Id finmb_266763185
Most Recent Quarter 1,767,139,200
Net Income To Common -31,001,000
Next Fiscal Year End 1,774,915,200
Non Diluted Market Cap 5,661,101
Number Of Analyst Opinions 3
Open 0.4987
Operating Cashflow -20,155,000
Operating Margins -3.00638
Payout Ratio 0.0
Phone 516 665 8200
Post Market Change -0.0052000284
Post Market Change Percent -0.9558875
Post Market Price 0.5388
Post Market Time 1,776,469,367
Previous Close 0.4452
Price Eps Current Year -0.13432099
Price Hint 4
Price To Book 0.5637306
Price To Sales Trailing12 Months 0.8272623
Profit Margins 0.0
Quick Ratio 2.59
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.75
Region US
Regular Market Change 0.0988
Regular Market Change Percent 22.1923
Regular Market Day High 0.5556
Regular Market Day Low 0.4726
Regular Market Day Range 0.4726 - 0.5556
Regular Market Open 0.4987
Regular Market Previous Close 0.4452
Regular Market Price 0.544
Regular Market Time 1,776,456,000
Regular Market Volume 1,717,707
Return On Assets -0.512
Return On Equity -2.40205
Revenue Growth 1.047
Revenue Per Share 1.131
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 10,529,344
Shares Percent Shares Out 0.0107
Shares Short 112,569
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 154,371
Short Name Beyond Air, Inc.
Short Percent Of Float 0.0112
Short Ratio 0.58
Source Interval 15
State NY
Symbol XAIR
Target High Price 14.0
Target Low Price 2.0
Target Mean Price 8.66667
Target Median Price 10.0
Total Cash 11,661,000
Total Cash Per Share 1.107
Total Debt 23,591,000
Total Revenue 6,924,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.47
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.755785
Two Hundred Day Average Change -1.211785
Two Hundred Day Average Change Percent -0.69016707
Type Disp Equity
Volume 1,717,707
Website https://www.beyondair.net
Zip 11,530